Metodura Znt

Metoprolol Tartrate, the active ingredient in Metodura Znt, is a beta blocker presented as an oral tablet for oral use. It treats hypertension, angina, post‑myocardial infarction care, chronic heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metodura Znt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Tartrate is employed to manage cardiovascular conditions that involve elevated blood pressure or cardiac workload.

- Hypertension: lowers systemic blood pressure by reducing heart rate and myocardial contractility. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: improves survival by limiting arrhythmias and remodeling. - Chronic heart failure: enhances ventricular function and reduces hospitalisation. - Cardiac arrhythmias: controls rate in supraventricular tachycardia and atrial fibrillation.

Metoprolol Tartrate may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness. - Cold extremities (hands and feet). - Gastrointestinal discomfort such as nausea. - Bradycardia (slow heart rate). - Sleep disturbances or vivid dreams.

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Marked hypotension. - Bronchospasm, especially in patients with asthma. - Depression or mood changes. - Allergic reactions including rash or angioedema. - Worsening heart failure.

When prescribing Metodura Znt, clinicians should consider several safety aspects.

- Assess cardiac function: evaluate baseline heart rate and blood pressure before initiation. - Monitor for bronchospasm: avoid in patients with uncontrolled asthma or severe chronic obstructive pulmonary disease. - Review diabetes therapy: beta‑blockade may mask hypoglycaemia symptoms. - Adjust in renal/hepatic impairment: dose may need modification in reduced clearance. - Discontinue gradually: abrupt cessation can precipitate rebound hypertension or tachycardia. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metodura Znt can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Calcium channel blockers (e.g., verapamil, diltiazem): risk of profound bradycardia. - Clonidine: abrupt withdrawal may cause severe rebound hypertension. - Other antihypertensives (e.g., ACE inhibitors, diuretics): additive blood‑pressure lowering effect. - Anti‑arrhythmic agents (e.g., amiodarone): may increase plasma concentrations of metoprolol.

Moderate Interactions (Monitor Closely): - NSAIDs: may attenuate antihypertensive response. - Antidepressants (e.g., SSRIs, SNRIs): potential increase in metoprolol levels. - Potassium‑sparing diuretics: heightened risk of hyperkalaemia.